HM11260C
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for HM11260C, covering 2014-02-07 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin [Phase 3]